John Kerbo
Family Medicine · Cincinnati, OHNPI 1881637460
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 266 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 30 manufacturers, the largest accounting for just 14.4% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,662 and has fallen 92.9% since, to $118 in 2023.
Across 266 payments — averaging $14.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$552
- Lilly USA, LLC$310
- Johnson & Johnson$305
- AstraZeneca$296
- Amgen$248
- Sanofi-aventis U.S. LLC$246
- plus $2K from 24 others
What the payments were for
- Food & beverage$3,72297%
- Education$1143%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 37 | $552 |
| Lilly USA, LLC | 26 | $310 |
| Johnson & Johnson | 26 | $305 |
| AstraZeneca | 8 | $296 |
| Amgen(2 entities) | 15 | $248 |
| Sanofi-aventis U.S. LLC | 17 | $246 |
| AbbVie(2 entities) | 16 | $233 |
| Pfizer | 23 | $229 |
| GSK | 20 | $215 |
| Astellas Pharma US Inc | 8 | $191 |
| Merck | 12 | $169 |
| Boehringer Ingelheim | 11 | $154 |
| Novartis | 9 | $119 |
| Amarin Pharma, Inc. | 6 | $99 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $74 |
| Phadia US Inc. | 4 | $64 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $42 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Sanofi | 2 | $32 |
| Radius Health, Inc. | 2 | $27 |
| Biohaven Pharmaceuticals, Inc. | 2 | $26 |
| Otsuka America Pharmaceutical, Inc. | 2 | $26 |
| Hikma Pharmaceuticals USA | 2 | $24 |
| Neos Therapeutics, LP | 2 | $24 |
| Upsher-smith Laboratories LLC | 1 | $19 |
| Exact Sciences | 1 | $19 |
| Bayer | 1 | $16 |
| Esperion Therapeutics, Inc. | 1 | $15 |
| Teva Pharmaceuticals USA, Inc. | 1 | $12 |
| Ironwood Pharmaceuticals, Inc | 1 | $12 |
How this compares
$3,836 in reported general payments places this provider in the 85th percentile of 3,983 family medicine providers in Ohio.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Metformin Hcl | 16 | $217 |
| Levothyroxine Sodium | 12 | $184 |
| Potassium Chloride | 12 | $112 |
Paid to pharmacies, not to this prescriber.
Other family medicine in Cincinnati
- Michael HeileCincinnati$272K
- Amy MechleyCincinnati$120K
- Melissa SchroerCincinnati$116K
- William CoxCincinnati$23K
- Jeffrey SusmanCincinnati$21K
- Ginger KubalaCincinnati$19K
- Kwabena OtengSpringdale$2M
- Brian BeesleyColumbus$1.4M
- Darshana PatelBeachwood$648K
- Thomas GraceFindlay$503K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.